世界の蠕虫感染症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Helminthic Infestations Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4294 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、蠕虫感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベンズイミダゾール、ピランテル、ピペラジンクエン酸塩、その他）、用途別市場規模（蟯虫、無鉤条虫、回虫、鞭虫、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・蠕虫感染症治療薬の市場動向 ・企業の競争状況、市場シェア ・蠕虫感染症治療薬の種類別市場規模と予測2016-2027（ベンズイミダゾール、ピランテル、ピペラジンクエン酸塩、その他） ・蠕虫感染症治療薬の用途別市場規模と予測2016-2027（蟯虫、無鉤条虫、回虫、鞭虫、その他） ・蠕虫感染症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・蠕虫感染症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・蠕虫感染症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・蠕虫感染症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・蠕虫感染症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Neural Analytics, Inc.、M3 Biotechnology, Inc.、Cerevance、Mitochon Pharmaceuticals, Inc.、Peptilogics、Farmoquimica S/A、biOasis Technologies, Inc.、HCA Healthcare, Inc.、Alzeca Biosciences, Inc.、Johnson & Johnson） ・結論

Market Analysis and Insights: Global Helminthic Infestations Therapeutics Market
The global Helminthic Infestations Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Helminthic Infestations Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Helminthic Infestations Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Helminthic Infestations Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Helminthic Infestations Therapeutics market.

Global Helminthic Infestations Therapeutics Scope and Market Size
Helminthic Infestations Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Helminthic Infestations Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Benzimidazole
Pyrantel
Piperazine Citrate
Others

Segment by Application
Enterobius vermicularis
Taenia saginata
Ascaris lumbricoides
Trichuris trichiura
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Neural Analytics, Inc.
M3 Biotechnology, Inc.
Cerevance
Mitochon Pharmaceuticals, Inc.
Peptilogics
Farmoquimica S/A
biOasis Technologies, Inc.
HCA Healthcare, Inc.
Alzeca Biosciences, Inc.
Johnson & Johnson

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Helminthic Infestations Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Benzimidazole
1.2.3 Pyrantel
1.2.4 Piperazine Citrate
1.2.5 Others
1.3 Market by Application
1.3.1 Global Helminthic Infestations Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Enterobius vermicularis
1.3.3 Taenia saginata
1.3.4 Ascaris lumbricoides
1.3.5 Trichuris trichiura
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Helminthic Infestations Therapeutics Market Perspective (2016-2027)
2.2 Helminthic Infestations Therapeutics Growth Trends by Regions
2.2.1 Helminthic Infestations Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Helminthic Infestations Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Helminthic Infestations Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Helminthic Infestations Therapeutics Industry Dynamic
2.3.1 Helminthic Infestations Therapeutics Market Trends
2.3.2 Helminthic Infestations Therapeutics Market Drivers
2.3.3 Helminthic Infestations Therapeutics Market Challenges
2.3.4 Helminthic Infestations Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Helminthic Infestations Therapeutics Players by Revenue
3.1.1 Global Top Helminthic Infestations Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Helminthic Infestations Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Helminthic Infestations Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Helminthic Infestations Therapeutics Revenue
3.4 Global Helminthic Infestations Therapeutics Market Concentration Ratio
3.4.1 Global Helminthic Infestations Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Helminthic Infestations Therapeutics Revenue in 2020
3.5 Helminthic Infestations Therapeutics Key Players Head office and Area Served
3.6 Key Players Helminthic Infestations Therapeutics Product Solution and Service
3.7 Date of Enter into Helminthic Infestations Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Helminthic Infestations Therapeutics Breakdown Data by Type
4.1 Global Helminthic Infestations Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Helminthic Infestations Therapeutics Forecasted Market Size by Type (2022-2027)

5 Helminthic Infestations Therapeutics Breakdown Data by Application
5.1 Global Helminthic Infestations Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Helminthic Infestations Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Helminthic Infestations Therapeutics Market Size (2016-2027)
6.2 North America Helminthic Infestations Therapeutics Market Size by Type
6.2.1 North America Helminthic Infestations Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Helminthic Infestations Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Helminthic Infestations Therapeutics Market Size by Type (2016-2027)
6.3 North America Helminthic Infestations Therapeutics Market Size by Application
6.3.1 North America Helminthic Infestations Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Helminthic Infestations Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Helminthic Infestations Therapeutics Market Size by Application (2016-2027)
6.4 North America Helminthic Infestations Therapeutics Market Size by Country
6.4.1 North America Helminthic Infestations Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Helminthic Infestations Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Helminthic Infestations Therapeutics Market Size (2016-2027)
7.2 Europe Helminthic Infestations Therapeutics Market Size by Type
7.2.1 Europe Helminthic Infestations Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Helminthic Infestations Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Helminthic Infestations Therapeutics Market Size by Type (2016-2027)
7.3 Europe Helminthic Infestations Therapeutics Market Size by Application
7.3.1 Europe Helminthic Infestations Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Helminthic Infestations Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Helminthic Infestations Therapeutics Market Size by Application (2016-2027)
7.4 Europe Helminthic Infestations Therapeutics Market Size by Country
7.4.1 Europe Helminthic Infestations Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Helminthic Infestations Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Helminthic Infestations Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Type
8.2.1 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Application
8.3.1 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region
8.4.1 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Helminthic Infestations Therapeutics Market Size (2016-2027)
9.2 Latin America Helminthic Infestations Therapeutics Market Size by Type
9.2.1 Latin America Helminthic Infestations Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Helminthic Infestations Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Helminthic Infestations Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Helminthic Infestations Therapeutics Market Size by Application
9.3.1 Latin America Helminthic Infestations Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Helminthic Infestations Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Helminthic Infestations Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Helminthic Infestations Therapeutics Market Size by Country
9.4.1 Latin America Helminthic Infestations Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Helminthic Infestations Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Helminthic Infestations Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Type
10.2.1 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Application
10.3.1 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country
10.4.1 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Neural Analytics, Inc.
11.1.1 Neural Analytics, Inc. Company Details
11.1.2 Neural Analytics, Inc. Business Overview
11.1.3 Neural Analytics, Inc. Helminthic Infestations Therapeutics Introduction
11.1.4 Neural Analytics, Inc. Revenue in Helminthic Infestations Therapeutics Business (2016-2021)
11.1.5 Neural Analytics, Inc. Recent Development
11.2 M3 Biotechnology, Inc.
11.2.1 M3 Biotechnology, Inc. Company Details
11.2.2 M3 Biotechnology, Inc. Business Overview
11.2.3 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Introduction
11.2.4 M3 Biotechnology, Inc. Revenue in Helminthic Infestations Therapeutics Business (2016-2021)
11.2.5 M3 Biotechnology, Inc. Recent Development
11.3 Cerevance
11.3.1 Cerevance Company Details
11.3.2 Cerevance Business Overview
11.3.3 Cerevance Helminthic Infestations Therapeutics Introduction
11.3.4 Cerevance Revenue in Helminthic Infestations Therapeutics Business (2016-2021)
11.3.5 Cerevance Recent Development
11.4 Mitochon Pharmaceuticals, Inc.
11.4.1 Mitochon Pharmaceuticals, Inc. Company Details
11.4.2 Mitochon Pharmaceuticals, Inc. Business Overview
11.4.3 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Introduction
11.4.4 Mitochon Pharmaceuticals, Inc. Revenue in Helminthic Infestations Therapeutics Business (2016-2021)
11.4.5 Mitochon Pharmaceuticals, Inc. Recent Development
11.5 Peptilogics
11.5.1 Peptilogics Company Details
11.5.2 Peptilogics Business Overview
11.5.3 Peptilogics Helminthic Infestations Therapeutics Introduction
11.5.4 Peptilogics Revenue in Helminthic Infestations Therapeutics Business (2016-2021)
11.5.5 Peptilogics Recent Development
11.6 Farmoquimica S/A
11.6.1 Farmoquimica S/A Company Details
11.6.2 Farmoquimica S/A Business Overview
11.6.3 Farmoquimica S/A Helminthic Infestations Therapeutics Introduction
11.6.4 Farmoquimica S/A Revenue in Helminthic Infestations Therapeutics Business (2016-2021)
11.6.5 Farmoquimica S/A Recent Development
11.7 biOasis Technologies, Inc.
11.7.1 biOasis Technologies, Inc. Company Details
11.7.2 biOasis Technologies, Inc. Business Overview
11.7.3 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Introduction
11.7.4 biOasis Technologies, Inc. Revenue in Helminthic Infestations Therapeutics Business (2016-2021)
11.7.5 biOasis Technologies, Inc. Recent Development
11.8 HCA Healthcare, Inc.
11.8.1 HCA Healthcare, Inc. Company Details
11.8.2 HCA Healthcare, Inc. Business Overview
11.8.3 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Introduction
11.8.4 HCA Healthcare, Inc. Revenue in Helminthic Infestations Therapeutics Business (2016-2021)
11.8.5 HCA Healthcare, Inc. Recent Development
11.9 Alzeca Biosciences, Inc.
11.9.1 Alzeca Biosciences, Inc. Company Details
11.9.2 Alzeca Biosciences, Inc. Business Overview
11.9.3 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Introduction
11.9.4 Alzeca Biosciences, Inc. Revenue in Helminthic Infestations Therapeutics Business (2016-2021)
11.9.5 Alzeca Biosciences, Inc. Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Helminthic Infestations Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Helminthic Infestations Therapeutics Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Helminthic Infestations Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Benzimidazole
Table 3. Key Players of Pyrantel
Table 4. Key Players of Piperazine Citrate
Table 5. Key Players of Others
Table 6. Global Helminthic Infestations Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Helminthic Infestations Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Helminthic Infestations Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Helminthic Infestations Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Helminthic Infestations Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Helminthic Infestations Therapeutics Market Share by Regions (2022-2027)
Table 12. Helminthic Infestations Therapeutics Market Trends
Table 13. Helminthic Infestations Therapeutics Market Drivers
Table 14. Helminthic Infestations Therapeutics Market Challenges
Table 15. Helminthic Infestations Therapeutics Market Restraints
Table 16. Global Helminthic Infestations Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Helminthic Infestations Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Helminthic Infestations Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Helminthic Infestations Therapeutics as of 2020)
Table 19. Ranking of Global Top Helminthic Infestations Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Helminthic Infestations Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Helminthic Infestations Therapeutics Product Solution and Service
Table 23. Date of Enter into Helminthic Infestations Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Helminthic Infestations Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Helminthic Infestations Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Helminthic Infestations Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Helminthic Infestations Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Helminthic Infestations Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Helminthic Infestations Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Helminthic Infestations Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Helminthic Infestations Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Helminthic Infestations Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Helminthic Infestations Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Helminthic Infestations Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Helminthic Infestations Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Helminthic Infestations Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Helminthic Infestations Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Helminthic Infestations Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Helminthic Infestations Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Helminthic Infestations Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Helminthic Infestations Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Helminthic Infestations Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Helminthic Infestations Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Helminthic Infestations Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Helminthic Infestations Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Helminthic Infestations Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Helminthic Infestations Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Helminthic Infestations Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Helminthic Infestations Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Helminthic Infestations Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Helminthic Infestations Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Helminthic Infestations Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Helminthic Infestations Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Helminthic Infestations Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Helminthic Infestations Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Helminthic Infestations Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Helminthic Infestations Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Neural Analytics, Inc. Company Details
Table 64. Neural Analytics, Inc. Business Overview
Table 65. Neural Analytics, Inc. Helminthic Infestations Therapeutics Product
Table 66. Neural Analytics, Inc. Revenue in Helminthic Infestations Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Neural Analytics, Inc. Recent Development
Table 68. M3 Biotechnology, Inc. Company Details
Table 69. M3 Biotechnology, Inc. Business Overview
Table 70. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Product
Table 71. M3 Biotechnology, Inc. Revenue in Helminthic Infestations Therapeutics Business (2016-2021) & (US$ Million)
Table 72. M3 Biotechnology, Inc. Recent Development
Table 73. Cerevance Company Details
Table 74. Cerevance Business Overview
Table 75. Cerevance Helminthic Infestations Therapeutics Product
Table 76. Cerevance Revenue in Helminthic Infestations Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Cerevance Recent Development
Table 78. Mitochon Pharmaceuticals, Inc. Company Details
Table 79. Mitochon Pharmaceuticals, Inc. Business Overview
Table 80. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Product
Table 81. Mitochon Pharmaceuticals, Inc. Revenue in Helminthic Infestations Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Mitochon Pharmaceuticals, Inc. Recent Development
Table 83. Peptilogics Company Details
Table 84. Peptilogics Business Overview
Table 85. Peptilogics Helminthic Infestations Therapeutics Product
Table 86. Peptilogics Revenue in Helminthic Infestations Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Peptilogics Recent Development
Table 88. Farmoquimica S/A Company Details
Table 89. Farmoquimica S/A Business Overview
Table 90. Farmoquimica S/A Helminthic Infestations Therapeutics Product
Table 91. Farmoquimica S/A Revenue in Helminthic Infestations Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Farmoquimica S/A Recent Development
Table 93. biOasis Technologies, Inc. Company Details
Table 94. biOasis Technologies, Inc. Business Overview
Table 95. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Product
Table 96. biOasis Technologies, Inc. Revenue in Helminthic Infestations Therapeutics Business (2016-2021) & (US$ Million)
Table 97. biOasis Technologies, Inc. Recent Development
Table 98. HCA Healthcare, Inc. Company Details
Table 99. HCA Healthcare, Inc. Business Overview
Table 100. HCA Healthcare, Inc. Revenue in Helminthic Infestations Therapeutics Business (2016-2021) & (US$ Million)
Table 101. HCA Healthcare, Inc. Recent Development
Table 102. Alzeca Biosciences, Inc. Company Details
Table 103. Alzeca Biosciences, Inc. Business Overview
Table 104. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Product
Table 105. Alzeca Biosciences, Inc. Revenue in Helminthic Infestations Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Alzeca Biosciences, Inc. Recent Development
Table 107. Johnson & Johnson Company Details
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Helminthic Infestations Therapeutics Product
Table 110. Johnson & Johnson Revenue in Helminthic Infestations Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Johnson & Johnson Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Helminthic Infestations Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Benzimidazole Features
Figure 3. Pyrantel Features
Figure 4. Piperazine Citrate Features
Figure 5. Others Features
Figure 6. Global Helminthic Infestations Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Enterobius vermicularis Case Studies
Figure 8. Taenia saginata Case Studies
Figure 9. Ascaris lumbricoides Case Studies
Figure 10. Trichuris trichiura Case Studies
Figure 11. Others Case Studies
Figure 12. Helminthic Infestations Therapeutics Report Years Considered
Figure 13. Global Helminthic Infestations Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Helminthic Infestations Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Helminthic Infestations Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Helminthic Infestations Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Helminthic Infestations Therapeutics Market Share by Players in 2020
Figure 18. Global Top Helminthic Infestations Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Helminthic Infestations Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Helminthic Infestations Therapeutics Revenue in 2020
Figure 20. Global Helminthic Infestations Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Helminthic Infestations Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Helminthic Infestations Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Helminthic Infestations Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Helminthic Infestations Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Helminthic Infestations Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Helminthic Infestations Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Helminthic Infestations Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Helminthic Infestations Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Helminthic Infestations Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Helminthic Infestations Therapeutics Market Share by Region (2016-2027)
Figure 42. China Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Helminthic Infestations Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Helminthic Infestations Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Helminthic Infestations Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Helminthic Infestations Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Helminthic Infestations Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Helminthic Infestations Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Helminthic Infestations Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Neural Analytics, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2016-2021)
Figure 62. M3 Biotechnology, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2016-2021)
Figure 63. Cerevance Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2016-2021)
Figure 64. Mitochon Pharmaceuticals, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2016-2021)
Figure 65. Peptilogics Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2016-2021)
Figure 66. Farmoquimica S/A Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2016-2021)
Figure 67. biOasis Technologies, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2016-2021)
Figure 68. HCA Healthcare, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2016-2021)
Figure 69. Alzeca Biosciences, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2016-2021)
Figure 70. Johnson & Johnson Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---